J Menzin

Summary

Affiliation: Boston Health Economics
Country: USA

Publications

  1. ncbi request reprint Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus
    Joseph Menzin
    Boston Health Economics, Inc, 20 Fox Rd, Waltham, MA 02451, USA
    J Manag Care Pharm 16:264-75. 2010
  2. ncbi request reprint Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data
    Kathleen Lang
    Boston Health Economics, Inc, Waltham, MA, USA
    BMC Health Serv Res 14:298. 2014
  3. pmc Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data
    Marya D Zilberberg
    Boston Health Economics, Inc, Waltham, MA, USA
    BMC Infect Dis 14:310. 2014
  4. pmc Impact of atrial fibrillation on stroke-related healthcare costs
    Matthew Sussman
    Boston Health Economics, Inc, Waltham, MA
    J Am Heart Assoc 2:e000479. 2013
  5. doi request reprint National trends in advanced outpatient diagnostic imaging utilization: an analysis of the medical expenditure panel survey, 2000-2009
    Kathleen Lang
    Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
    BMC Med Imaging 13:40. 2013
  6. ncbi request reprint Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis
    Joseph Menzin
    Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 0245, USA
    J Manag Care Pharm 19:S24-40. 2013
  7. pmc The economic burden of advanced liver disease among patients with hepatitis C virus: a large state Medicaid perspective
    Joseph Menzin
    Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
    BMC Health Serv Res 12:459. 2012
  8. pmc Lost productivity due to premature mortality in developed and emerging countries: an application to smoking cessation
    Joseph Menzin
    Boston Health Economics, Inc, Waltham, MA 02451, USA
    BMC Med Res Methodol 12:87. 2012
  9. doi request reprint Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records
    J Menzin
    Outcomes Research, Boston Health Economics, Inc, Waltham, MA 02451, USA
    J Thromb Haemost 10:596-605. 2012
  10. doi request reprint Factors associated with failure to correct the international normalised ratio following fresh frozen plasma administration among patients treated for warfarin-related major bleeding. An analysis of electronic health records
    J Menzin
    Joseph Menzin, PhD, Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
    Thromb Haemost 107:662-72. 2012

Detail Information

Publications50

  1. ncbi request reprint Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus
    Joseph Menzin
    Boston Health Economics, Inc, 20 Fox Rd, Waltham, MA 02451, USA
    J Manag Care Pharm 16:264-75. 2010
    ..However, limited data from clinical practice are available regarding the relationship between glycemic control and medical costs associated with diabetes care...
  2. ncbi request reprint Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data
    Kathleen Lang
    Boston Health Economics, Inc, Waltham, MA, USA
    BMC Health Serv Res 14:298. 2014
    ..Few studies have evaluated survival, treatment, resource use, and costs among women with stage IV ER + breast cancer (BC) who did not receive HER2 targeted therapy...
  3. pmc Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data
    Marya D Zilberberg
    Boston Health Economics, Inc, Waltham, MA, USA
    BMC Infect Dis 14:310. 2014
    ..The aim of this study was to evaluate inpatient mortality, length of stay (LOS), and costs among a matched sample of high-risk patients with and without mucormycosis in a large nationally representative database...
  4. pmc Impact of atrial fibrillation on stroke-related healthcare costs
    Matthew Sussman
    Boston Health Economics, Inc, Waltham, MA
    J Am Heart Assoc 2:e000479. 2013
    ..This study assesses the impact of AF on healthcare costs associated with ischemic stroke (IS), hemorrhagic stroke (HS), or transient ischemic attack (TIA)...
  5. doi request reprint National trends in advanced outpatient diagnostic imaging utilization: an analysis of the medical expenditure panel survey, 2000-2009
    Kathleen Lang
    Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
    BMC Med Imaging 13:40. 2013
    ..Concerns have been raised regarding growth in advanced diagnostic imaging use. This study evaluated trends in national outpatient MRI/CT utilization rates during 2000-2009 and factors associated with utilization...
  6. ncbi request reprint Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis
    Joseph Menzin
    Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 0245, USA
    J Manag Care Pharm 19:S24-40. 2013
    ..Improvements in adherence have the potential to improve patient and payer burden in terms of improved clinical outcomes and lower nonpharmacy medical resource utilization.  ..
  7. pmc The economic burden of advanced liver disease among patients with hepatitis C virus: a large state Medicaid perspective
    Joseph Menzin
    Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
    BMC Health Serv Res 12:459. 2012
    ..ALD can lead to significant clinical and economic consequences, including liver transplantation. This study evaluated the health care costs associated with ALD among HCV infected patients in a Medicaid population...
  8. pmc Lost productivity due to premature mortality in developed and emerging countries: an application to smoking cessation
    Joseph Menzin
    Boston Health Economics, Inc, Waltham, MA 02451, USA
    BMC Med Res Methodol 12:87. 2012
    ..The estimation of indirect costs is commonly done on a country-specific basis. However, there are few studies that evaluate indirect costs across countries using a consistent methodology...
  9. doi request reprint Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records
    J Menzin
    Outcomes Research, Boston Health Economics, Inc, Waltham, MA 02451, USA
    J Thromb Haemost 10:596-605. 2012
    ..However, there are limited data on the association between INR correction and mortality...
  10. doi request reprint Factors associated with failure to correct the international normalised ratio following fresh frozen plasma administration among patients treated for warfarin-related major bleeding. An analysis of electronic health records
    J Menzin
    Joseph Menzin, PhD, Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
    Thromb Haemost 107:662-72. 2012
    ..5), 39% of patients' INRs remained uncorrected. For a substantial proportion of patients, the INRs remain inadequately or uncorrected following FFP administration, with estimates varying depending on the INR threshold used...
  11. pmc Trends in healthcare utilization among older Americans with colorectal cancer: a retrospective database analysis
    Kathleen Lang
    Boston Health Economics, Inc, Waltham, MA, USA
    BMC Health Serv Res 9:227. 2009
    ..This retrospective cohort study evaluated healthcare resource use among US Medicare beneficiaries diagnosed with CRC between 1992 and 2002...
  12. pmc Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis
    Kathleen Lang
    Boston Health Economics, Inc, Waltham, USA
    BMC Cancer 9:227. 2009
    ..The purpose of this study was to estimate the relative impact of changes in demographics, stage at detection, treatment mix, and medical technology on 5-year survival among older colorectal cancer (CRC) patients...
  13. doi request reprint The economic costs to United States hospitals of invasive fungal infections in transplant patients
    Joseph Menzin
    Boston Health Economics, Waltham, MA 02451, USA
    Am J Infect Control 39:e15-20. 2011
    ..Data on the economic burden of IFIs in the United States are sparse...
  14. ncbi request reprint One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database
    Joseph Menzin
    Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
    Curr Med Res Opin 24:461-8. 2008
    ..Acute coronary syndromes (ACS) are life-threatening disorders requiring intensive medical management or invasive cardiovascular procedures. Limited data exist on the costs and resource utilization associated with ACS...
  15. doi request reprint The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population
    Joseph Menzin
    Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
    Respir Med 102:1248-56. 2008
    ..Although the economic burden of COPD has gained attention in recent years, data on the costs of COPD among U.S. Medicare beneficiaries are lacking...
  16. doi request reprint Cost analysis of amlodipine versus enalapril in patients with coronary artery disease and normal blood pressure: findings from the CAMELOT economic substudy
    Joseph Menzin
    Boston Health Economics, Inc, Waltham, Massachusetts, USA
    Appl Health Econ Health Policy 6:157-62. 2008
    ..To analyse 2-year hospitalization and cost data collected during a prospective, double-blind, randomized, controlled trial comparing amlodipine, enalapril and placebo in normotensive patients with coronary artery disease (CAD)...
  17. doi request reprint Estimating the short-term clinical and economic benefits of smoking cessation: do we have it right?
    Joseph Menzin
    Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
    Expert Rev Pharmacoecon Outcomes Res 9:257-64. 2009
    ..Nonetheless, the policy and social welfare implications of a short-term focus must be carefully evaluated, considering the established favorable long-term cost-effectiveness of smoking cessation...
  18. ncbi request reprint A model of the economic impact of a bipolar disorder screening program in primary care
    Joseph Menzin
    Boston Health Economics, Inc, 20 Fox Rd, Waltham, MA 02451, USA
    J Clin Psychiatry 70:1230-6. 2009
    ..This study models the cost effectiveness of screening for bipolar disorder among adults presenting for the first time with symptoms of major depressive disorder...
  19. doi request reprint Inpatient treatment patterns, outcomes, and costs of skin and skin structure infections because of Staphylococcus aureus
    Joseph Menzin
    Boston Health Economics, Inc, Waltham, MA 02451, USA
    Am J Infect Control 38:44-9. 2010
    ..Staphylococcus aureus (SA) is a common bacterial pathogen in skin and skin structure infections (SSSIs). Limited data exist on hospital treatment patterns and costs for SA-SSSIs...
  20. doi request reprint Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients
    Joseph Menzin
    Boston Health Economics, Inc, Waltham, MA 02451, USA
    Am J Health Syst Pharm 66:1711-7. 2009
    ..The mortality, length of hospitalization, and costs associated with invasive fungal infections (IFIs) in hospitalized patients were studied...
  21. doi request reprint A review of the costs and cost effectiveness of interventions in chronic kidney disease: implications for policy
    Joseph Menzin
    Boston Health Economics, Inc, Waltham, MA, USA
    Pharmacoeconomics 29:839-61. 2011
    ..In order to realize these cost savings, efforts will be required to promote and effectively implement changes in treatment practices...
  22. ncbi request reprint The economics of squamous cell carcinoma of the head and neck
    Joseph Menzin
    Boston Health Economics, Inc, Waltham, Massachusetts 02451, USA
    Curr Opin Otolaryngol Head Neck Surg 15:68-73. 2007
    ..SCCHN is a relatively deadly disease. Approximately 50% of patients survive to 5 years, and surgery and chemoradiotherapy can leave survivors with pain, disfigurement, and disability that further add to the burden of the disease...
  23. ncbi request reprint Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid program
    Joseph Menzin
    Boston Health Economics Inc, 20 Fox Road, Waltham, MA 02451, USA
    Psychiatr Serv 54:719-23. 2003
    ..Rates of medication adherence over a one-year period were assessed among outpatients with schizophrenia who initiated therapy with conventional or atypical antipsychotic agents...
  24. ncbi request reprint Adherence to calcium channel blocker therapy in older adults: a comparison of amlodipine and felodipine
    J Menzin
    Boston Health Economics, Inc, Waltham, MA, USA
    J Int Med Res 32:233-9. 2004
    ..This study suggests that use of amlodipine may be associated with improved adherence, compared with felodipine, among older out-patients in the Medi-Cal program...
  25. ncbi request reprint Potential short-term economic benefits of improved glycemic control: a managed care perspective
    J Menzin
    Boston Health Economics, Billerica, Massachusetts 01821, USA
    Diabetes Care 24:51-5. 2001
    ..The goal of this study was to examine the potential impact of improved glycemic control on selected short-term complications of diabetes and associated costs in a managed care setting...
  26. ncbi request reprint Treatment patterns, outcomes and costs among elderly patients with chronic myeloid leukaemia: a population-based analysis
    Joseph Menzin
    Boston Health Economics, Inc, Waltham, Massachusetts, USA
    Drugs Aging 21:737-46. 2004
    ..To fill this void, our study uses population-based data to evaluate longer-term treatment patterns, outcomes and costs among elderly Medicare beneficiaries following their diagnosis of CML...
  27. ncbi request reprint Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study
    Joseph Menzin
    Boston Health Economics, 20 Fox Road, Waltham, MA 02451 1007, USA
    Ann Pharmacother 39:446-51. 2005
    ..Anticoagulation clinics are often used to administer warfarin therapy more effectively...
  28. ncbi request reprint Excess mortality, length of stay, and costs associated with serious fungal infections among elderly cancer patients: findings from linked SEER-Medicare data
    Joseph Menzin
    Boston Health Economics, Waltham, MA 02451, USA
    Value Health 8:140-8. 2005
    ....
  29. ncbi request reprint The outcomes and costs of acute myeloid leukemia among the elderly
    Joseph Menzin
    Boston Health Economics, Inc, 20 Fox Rd, Waltham, MA 02451, USA
    Arch Intern Med 162:1597-603. 2002
    ..The incidence of acute myeloid leukemia (AML) among the elderly can be expected to grow as the population continues to age. However, data on current treatment practices and costs for this form of cancer are sparse...
  30. ncbi request reprint A general model of the effects of sleep medications on the risk and cost of motor vehicle accidents and its application to France
    J Menzin
    Boston Health Economics, Inc, Billerica, Massachusetts, USA
    Pharmacoeconomics 19:69-78. 2001
    ..Although various prescription drugs may be equally effective in promoting sleep, some may lead to substantial impairment in psychomotor functioning and an increased risk of motor vehicle accidents...
  31. ncbi request reprint Warfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillation
    Luke Boulanger
    Boston Health Economics, Waltham, MA 02451, USA
    Ann Pharmacother 40:1024-9. 2006
    ..Outcomes of anticoagulation have been assessed in commercially insured populations, but similar data do not exist for Medicaid populations...
  32. ncbi request reprint Trends in the treatment of acute myeloid leukaemia in the elderly
    Kathleen Lang
    Boston Health Economics, Inc, Waltham, Massachusetts 02451, USA
    Drugs Aging 22:943-55. 2005
    ..This study documents changes in treatment patterns and outcomes among elderly AML patients over the past decade...
  33. doi request reprint Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck
    Kathleen Lang
    Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
    Arch Otolaryngol Head Neck Surg 135:582-8. 2009
    ..To evaluate the incidence and costs of complications due to radiotherapy alone vs platinum-based chemoradiotherapy among patients diagnosed as having advanced squamous cell carcinoma of the head and neck (ASCCHN) from a payer perspective...
  34. ncbi request reprint Patterns of use of antithrombotic therapy and quality of anticoagulation among patients with non-valvular atrial fibrillation in clinical practice
    L Boulanger
    Boston Health Economics, Waltham, MA 02451, USA
    Int J Clin Pract 60:258-64. 2006
    ..Our study confirms that, in routine medical practice, warfarin is not prescribed for substantial numbers of eligible patients, and anticoagulation control with warfarin is suboptimal for many of those at risk for thromboembolism...
  35. ncbi request reprint Cost-effectiveness of migraine prevention: the case of topiramate in the UK
    J S Brown
    Harvard Medical School Harvard Pilgrim Health Care, Department of Ambulatory Care and Prevention, Boston, MA, USA
    Cephalalgia 26:1473-82. 2006
    ..This analysis suggests that topiramate is a cost-effective treatment for migraine prevention compared with no preventive treatment...
  36. ncbi request reprint The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data
    Kathleen Lang
    Boston Health Economics Inc, Waltham, Mass, USA
    Arch Otolaryngol Head Neck Surg 130:1269-75. 2004
    ..To evaluate the excess mortality, resource use, and costs associated with squamous cell carcinoma of the head and neck (SCCHN) among elderly Medicare beneficiaries...
  37. ncbi request reprint Predictors of hospital length of stay and cost in patients with intracerebral hemorrhage
    M W Russell
    Boston Health Economics, Waltham, MA 02451, USA
    Neurology 67:1279-81. 2006
    ..Mean LOS (cost) was 7.7 days (15,256 dollars) (survivors: 9.6 days, 17,442 dollars). Patient, hospital, and payer characteristics accounted for 69.1% of variation in cost per discharge...
  38. ncbi request reprint Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature
    Talia S Foster
    Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
    COPD 3:211-8. 2006
    ..Cost-of-illness studies using recent data underscore the substantial current cost burden of COPD in the U.S...
  39. ncbi request reprint The economic burden of intracerebral hemorrhage: evidence from managed care
    Mason W Russell
    Boston Health Economics, Waltham, Massachusetts 02451, USA
    Manag Care Interface 19:24-8, 34. 2006
    ..Treatment costs for ICH to private payers appear to be considerable and may reflect a sizable long-term financial burden to U.S. health plans...
  40. ncbi request reprint Direct costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) data
    Jeffrey D Miller
    Boston Health Economics, Inc, 20 Fox Road, Waltham, Massachusetts 02451, USA
    COPD 2:311-8. 2005
    ..Results of our study indicate that COPD-associated healthcare utilization and expenditures are considerable, and that annual per-patient costs of COPD are comparable to those of other chronic diseases of the middle-aged and elderly...
  41. ncbi request reprint Effect of the Heart At Work program on awareness of risk factors, self-efficacy, and health behaviors
    Cheryl Pegus
    Pfizer, Inc, New York, N Y, USA
    J Occup Environ Med 44:228-36. 2002
    ..They also were more likely to begin treatment for hypertension, to report fewer sick days, and to have plans to improve their diet and lose weight. These findings suggest that the Heart At Work program had a favorable overall impact...
  42. ncbi request reprint Excess mortality, length of stay, and costs associated with serious hemorrhage among trauma patients: findings from the National Trauma Data Bank
    Luke Boulanger
    Boston Health Economics, Inc, Waltham, MA 02451, USA
    Am Surg 73:1269-74. 2007
    ..05). In both blunt and penetrating trauma cases, serious hemorrhage is significantly associated with excess mortality, longer hospital stays, and higher costs...
  43. doi request reprint Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data
    Kathleen Lang
    Boston Health Economics, Inc, Waltham, Massachusetts 02451, USA
    Clin Gastroenterol Hepatol 7:198-204. 2009
    ..This study provides detailed estimates of lifetime and phase-specific colorectal cancer (CRC) treatment costs...
  44. doi request reprint Quality-adjusted life years in cancer: pros, cons, and alternatives
    R M Woodward
    Boston Health Economics, Inc, Waltham, MA 02451, USA
    Eur J Cancer Care (Engl) 22:12-9. 2013
    ..In this paper, we summarise the use of the quality-adjusted life years to assess the value of cancer care and suggest potential ways to improve upon value measurement in cancer coverage and reimbursement decisions...
  45. ncbi request reprint Outcomes in patients treated with gemtuzumab ozogamicin for relapsed acute myelogenous leukemia
    Kathleen Lang
    Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
    Am J Health Syst Pharm 59:941-8. 2002
    ..Gemtuzumab ozogamicin appeared to be associated with equivalent survival and fewer total days of hospitalization than conventional chemotherapy in adults with relapsed AML...
  46. doi request reprint Migraine frequency and health utilities: findings from a multisite survey
    Jeffrey S Brown
    Department of Ambulatory Care and Prevention, Harvard Medical School Harvard Pilgrim Health Care, Boston, MA, USA
    Value Health 11:315-21. 2008
    ..Assess the relationship between migraine frequency and health utility...
  47. ncbi request reprint Neuromuscular blockade, reversal agent use, and operating room time: retrospective analysis of US inpatient surgeries
    Bin Zhang
    Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
    Curr Med Res Opin 25:943-50. 2009
    ..Specifically, this study sought to test the hypothesis that the application of reversal agents in surgeries using a neuromuscular block would be associated with a decrease in elapsed OR time...
  48. ncbi request reprint Cost effectiveness of topiramate in the prevention of migraines in the United States: an update
    Jeffrey S Brown
    Boston Health Economics, Inc, Waltham, Massachusetts 02451, USA
    Manag Care Interface 19:31-8. 2006
    ..Model results were sensitive to baseline migraine-days, response probability, and probability of an attack being treated with a triptan. Topiramate may be a cost-effective treatment for the prevention of migraine...
  49. ncbi request reprint Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment
    Jeffrey S Brown
    Boston Health Economics, Inc, Waltham, MA 02451, USA
    Headache 45:1012-22. 2005
    ..This cost-effectiveness model assesses the clinical and economic impact of topiramate (TPM) therapy versus no preventive treatment for migraine headache in the United States...
  50. ncbi request reprint Assessing the costs of chronic obstructive pulmonary disease: the state medicaid perspective
    Jeno P Marton
    Pfizer Inc, New York, NY 10017, USA
    Respir Med 100:996-1005. 2006
    ..State Medicaid programs provide insurance coverage to over 40 million Americans. However, estimates of the annual cost of chronic obstructive pulmonary disease (COPD) from the Medicaid perspective are lacking...